NEW YORK (GenomeWeb News) – Richard Shippy has joined Illumina as director of global product marketing for clinical genomics within the San Diego firm's diagnostics division.

In his new role, Shippy will be responsible for product marketing activities covering clinical genomics with an emphasis on cytogenomics, and will be working with BlueGnome to advance array designs for that market segment. Illumina acquired BlueGnome in September.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.